C&L: PDL BioPharma's L. Patrick Gage resigns

PDL BioPharma director and interim Chief Executive L. Patrick Gage resigned due to differences among the board about prioritizing company goals.
 
Histogenics has named F. Ken Andrews president and CEO. Andrews is a former vice president of marketing and sales of the tissue repair division of Genzyme.
 
Epix Pharmaceuticals announced the resignation of Dr. Andrew Uprichard from his position as president and head of research and development.
 
Alexza Pharmaceuticals announced that Jeffrey S. Williams has rejoined the company in a part-time position as president, Alexza Singapore, a wholly owned subsidiary of Alexza.
 
Biogen Idec has promoted Hans Peter Hasler to chief operating officer. He had been executive vice president, global neurology.
 
Etrials Worldwide said James W. Clark, Jr. has resigned his position as secretary, treasurer and chief financial officer.
 
Genmab AS said it has appointed David Eatwell as new chief financial officer of the group.
 
Amazon Biotech announced that Dr. Michael Silver has been appointed as the company's new scientific director.
 
ImClone Systems has appointed Bernhard Ehmer, M.D. as senior vice president and managing director, international operations.
 
Adolor Corporation has promoted Lee Techner, DPM to vice president, medical affairs and medical director.
 
MAP Pharmaceuticals has appointed Marco F. Rosa to the newly created position of vice president of human resources.
 
Stem Cell Therapeutics Corp. has appointed Thomas Franck as vice president of commercial planning.
 
BioChemics has named Dr. R. Rox Anderson, professor at Harvard Medical School, as a member of the company's Scientific Advisory Board.
 
DermTech announced that Herbert A. Fritsche, Ph.D., has joined DermTech's Scientific Advisory Board.
 
Avantogen Ltd welcomed Professor Ian Frazer to the Scientific Advisory Board of Hawaii Biotech Inc.
 
Provectus Pharmaceuticals has announced that Kelly M. McMasters MD, PhD, has agreed to serve as a member of the corporate board of directors. Additionally, Dr. McMasters will head the scientific advisory board.
 
TOPIGEN Pharmaceuticals has named Jeremy Curnock Cook, MA, to its board of directors.
 
Trius Therapeutics announced the appointment of Paul Truex to its board of directors.
 
NanoBio announced the appointment of David M. Stout to its board of directors.
 
Enzon Pharmaceuticals announced that Dr. Jack Geltosky has been appointed to the company's board of directors

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.